On 2025-11-10, Avidity Biosciences, Inc. (RNA) announced earnings per share of $-1.27 for the fiscal quarter ending 2025-09-30, missing the average analyst estimate of $-1.05.
The next expected annoucement date for quarterly earnings is 2026-02-26, with an average estimated earnings per share of $-1.11 for the fiscal quarter ending 2025-12-31.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-11-10 | 2025-09-30 | $-1.05 | $-1.27 |
| 2025-08-07 | 2025-06-30 | $-0.95 | $-1.21 |
| 2025-05-08 | 2025-03-31 | $-0.88 | $-0.90 |
| 2025-02-27 | 2024-12-31 | $-0.84 | $-0.80 |
| 2024-11-07 | 2024-09-30 | $-0.79 | $-0.65 |
| 2024-08-09 | 2024-06-30 | $-0.76 | $-0.65 |
| 2024-05-09 | 2024-03-31 | $-0.81 | $-0.79 |
| 2024-02-28 | 2023-12-31 | $-0.54 | $-0.79 |
| 2023-11-08 | 2023-09-30 | $-0.76 | $-0.71 |
| 2023-08-08 | 2023-06-30 | $-0.84 | $-0.66 |
| 2023-05-09 | 2023-03-31 | $-0.90 | $-0.74 |
| 2023-02-28 | 2022-12-31 | $-0.84 | $-0.88 |
| 2022-11-08 | 2022-09-30 | $-0.97 | $-0.82 |
| 2022-08-09 | 2022-06-30 | $-0.74 | $-0.92 |
| 2022-05-10 | 2022-03-31 | $-0.94 | $-0.71 |
| 2022-03-01 | 2021-12-31 | $-0.73 | $-0.82 |
| 2021-11-09 | 2021-09-30 | $-0.63 | $-0.68 |
| 2021-08-09 | 2021-06-30 | $-0.77 | $-0.70 |
| 2021-05-12 | 2021-03-31 | $-0.52 | $-0.64 |
| 2021-03-15 | 2020-12-31 | -- | $-0.43 |
| 2020-11-10 | 2020-09-30 | $-0.32 | $-0.31 |
| 2020-08-10 | 2020-06-30 | $-0.21 | $-1.23 |